Actions from call:
- TS – confirm with MoA WG that wording on diflovidazin is acceptable and finalise v7.0 of classification
- AP – obtain quote for printing 2nd editions of the MoA booklet and Vector Manual for Exec approval
- AP – update content of eConnection No 24 and circulate a final draft to the WG for proofing and approval
- RN/AP – follow up and make proposal (incl. date) to the Exec for the next Spring Meeting at CLI, Brussels
- AP – organise next C&E call in November after the Exec call